Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

What 9 Analyst Ratings Have To Say About Diversey Hldgs

Diversey Hldgs (NASDAQ:DSEY) has observed the following analyst ratings within the last quarter:

Benzinga

Analyst Ratings for 89bio

89bio (NASDAQ:ETNB) has observed the following analyst ratings within the last quarter:

Benzinga

Zosano Pharma: Q1 Earnings Insights

Zosano Pharma (NASDAQ:ZSAN) reported its Q1 earnings results on Friday, May 13, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Zosano Pharma reported in-line EPS of $-1.75 versus an estimate of $-1.75.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

If You Invested $1,000 In Ethereum Classic, Dogecoin And Ripple (XRP) In March 2020, Here's How Much You'd Have Now

Investors who have put money into major U.S. indices have enjoyed respectable returns since March 2020.

Benzinga

PreMarket Prep Stock Of The Day: Affirm's Q3 Earnings Rip

When a stock has been on your “buy” radar and has been going straight down for months, it's hard to pull the trigger to get long. On the other hand, when the stock puts in a potential bottom and then explodes after an earnings report, the question is whether to chase…

Benzinga

Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94

Benzinga

Cannabis Stock Movers For May 13, 2022

GAINERS: Heritage Cannabis Holding (OTC:HERTF) shares closed up 51.28% at $0.06

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Where CuriosityStream Stands With Analysts

CuriosityStream (NASDAQ:CURI) has observed the following analyst ratings within the last quarter:

Benzinga

Where LegalZoom.com Stands With Analysts

Within the last quarter, LegalZoom.com (NASDAQ:LZ) has observed the following analyst ratings:

Benzinga

Where Proterra Stands With Analysts

Within the last quarter, Proterra (NASDAQ:PTRA) has observed the following analyst ratings:

Benzinga

Check Out What Whales Are Doing With Micron Technology

Someone with a lot of money to spend has taken a bearish stance on Micron Technology (NASDAQ:MU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Expert Ratings for CyberArk Software

Within the last quarter, CyberArk Software (NASDAQ:CYBR) has observed the following analyst ratings:

Benzinga

Where ChromaDex Stands With Analysts

Within the last quarter, ChromaDex (NASDAQ:CDXC) has observed the following analyst ratings:

Benzinga

Check Out What Whales Are Doing With UPST

Someone with a lot of money to spend has taken a bearish stance on Upstart Hldgs (NASDAQ:UPST). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Twitter CEO Gives Update On Musk M&A, Company's Future: Here's What He Said

Following the news of Tesla (NASDAQ: TSLA) CEO Elon Musk putting his acquisition of Twitter (NYSE: TWTR)

Benzinga

Markets Finish Sharply Higher Amid Ongoing Macro Concerns

U.S. indices traded sharply higher Friday following recent weakness. Markets were highly volatile this week, selling off following the April CPI report, which showed worse-than-expected inflation.

Benzinga

Could Peloton's New Rower Provide A Rally For Beaten-Down Stock?

Connected fitness company Peloton Interactive (NASDAQ: PTON) unveiled a new product Thursday. Here’s the latest and what it could mean.

Benzinga

Why These 3 CyberArk Analysts Cut Price Targets Despite Q1 Beat-And-Raise

Although Cyberark Software Ltd (NASDAQ: CYBR) reported disappointing first-quarter revenue of $127.6 million, its earnings were better than Street ex

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

5 Analysts Have This to Say About NeuroPace

Over the past 3 months, 5 analysts have published their opinion on NeuroPace (NASDAQ:NPCE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

Benzinga

Expert Ratings for Arcellx

Analysts have provided the following ratings for Arcellx (NASDAQ:ACLX) within the last quarter:

Benzinga

10 Information Technology Stocks Moving In Friday's Intraday Session

Benzinga

Analyst Ratings for Graphite Bio

Over the past 3 months, 5 analysts have published their opinion on Graphite Bio (NASDAQ:GRPH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Duolingo Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite adding 400 points on Friday.

1 … 485 486 487 488

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.